Case–control association study of GRIA1, GRIA2 and GRIA4 polymorphisms in bipolar disorder

References

• Danysz W, Parsons CG. Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol Rev 1998;50(4):597–664.
   Google Scholar
• Preskorn SH, Baker B, Kolluri S, Menniti FS, Krams M, Landen JW. An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder. J Clin Psychopharmacol 2008;28(6):631–7.
   PubMedGoogle Scholar
• Nakanishi N, Shneider NA, Axel R. A family of glutamate receptor genes: evidence for the formation of heteromultimeric receptors with distinct channel properties. Neuron 1990;5(5):569–81.
   Google Scholar
• Wenthold RJ, Petralia RS, Blahos J II, Niedzielski AS. Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons. J Neurosci 1996;16(6):1982–9.
   Google Scholar
• Wenthold RJ, Yokotani N, Doi K, Wada K. Immunochemical characterization of the non-NMDA glutamate receptor using subunit-specific antibodies. Evidence for a hetero-oligomeric structure in rat brain. J Biol Chem 1992;267(1):501–7.
   Google Scholar
• Hollmann M, Hartley M, Heinemann S. Ca2+ permeability of KA-AMPA – gated glutamate receptor channels depends on subunit composition. Science 1991;252(5007):851–3.
   Google Scholar
• Bleakman D, Alt A, Witkin JM. AMPA receptors in the therapeutic management of depression. CNS Neurol Disord Drug Targets 2007;6(2):117–26.
   Google Scholar
• Schmitt WB, Sprengel R, Mack V, Draft RW, Seeburg PH, Deacon RM, . Restoration of spatial working memory by genetic rescue of GluR-A-deficient mice. Nat Neurosci 2005;8(3):270–2.
   Google Scholar
• Kerner B, Jasinska AJ, DeYoung J, Almonte M, Choi OW, Freimer NB. Polymorphisms in the GRIA1 gene region in psychotic bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2009;150B(1):24–32.
   Google Scholar
• Magri C, Gardella R, Barlati SD, Podavini D, Iatropoulos P, Bonomi S, . Glutamate AMPA receptor subunit 1 gene (GRIA1) and DSM-IV-TR schizophrenia: a pilot case- control association study in an Italian sample. Am J Med Genet B Neuropsychiatr Genet 2006;141B(3):287–93.
   Google Scholar
• O'Connor JA, Hemby SE. Elevated GRIA1 mRNA expression in Layer II/III and V pyramidal cells of the DLPFC in schizophrenia. Schizophr Res 2007;97(1–3):277–88.
   Google Scholar
• Beneyto M, Kristiansen LV, Oni-Orisan A, McCullumsmith RE, Meador-Woodruff JH. Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacology 2007;32(9): 1888–902.
   Google Scholar
• Black MD. Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data. Psychopharmacology (Berlin) 2005;179(1):154–63.
   PubMed Web of Science ®Google Scholar
• Ekholm JM, Kieseppa T, Hiekkalinna T, Partonen T, Paunio T, Perola M, . Evidence of susceptibility loci on 4q32 and 16p12 for bipolar disorder. Hum Mol Genet 2003;12(15):1907–15.
   Google Scholar
• McInnis MG, Lan TH, Willour VL, McMahon FJ, Simpson SG, Addington AM, . Genome-wide scan of bipolar disorder in 65 pedigrees: supportive evidence for linkage at 8q24, 18q22, 4q32, 2p12, and 13q12. Mol Psychiatry 2003;8(3):288–98.
   Google Scholar
• Hovatta I, Varilo T, Suvisaari J, Terwilliger JD, Ollikainen V, Arajarvi R, . A genomewide screen for schizophrenia genes in an isolated Finnish subpopulation, suggesting multiple susceptibility loci. Am J Hum Genet 1999; 65(4):1114–24.
   Google Scholar
• Perlis RH, Smoller JW, Ferreira MA, McQuillin A, Bass N, Lawrence J, . A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder. Am J Psychiatry 2009;166(6):718–25.
   Google Scholar
• Seelan RS, Khalyfa A, Lakshmanan J, Casanova MF, Parthasarathy RN. Deciphering the lithium transcriptome: microarray profiling of lithium-modulated gene expression in human neuronal cells. Neuroscience 2008;151(4):1184–97.
   Google Scholar
• Du J, Creson TK, Wu LJ, Ren M, Gray NA, Falke C, . The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior. J Neurosci 2008;28(1):68–79.
   Google Scholar
• Makino C, Fujii Y, Kikuta R, Hirata N, Tani A, Shibata A, . Positive association of the AMPA receptor subunit GluR4 gene (GRIA4) haplotype with schizophrenia: linkage disequilibrium mapping using SNPs evenly distributed across the gene region. Am J Med Genet B Neuropsychiatr Genet 2003;116B(1):17–22.
   Google Scholar
• Guo S, Shi Y, Zhao X, Duan S, Zhou J, Meng J, . No genetic association between polymorphisms in the AMPA receptor subunit GluR4 gene (GRIA4) and schizophrenia in the Chinese population. Neurosci Lett 2004;369(2):168–72.
   Google Scholar
• Magri C, Gardella R, Valsecchi P, Barlati SD, Guizzetti L, Imperadori L, . Study on GRIA2, GRIA3 and GRIA4 genes highlights a positive association between schizophrenia and GRIA3 in female patients. Am J Med Genet B Neuropsychiatr Genet 2008;147B(6):745–53.
   Google Scholar
• Giegling I, Drago A, Dolzan V, Plesnicar BK, Schafer M, Hartmann AM, . Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. Pharmacogenet Genomics 2011;21(4):206–16.
   Google Scholar
• Cherlyn SY, Woon PS, Liu JJ, Ong WY, Tsai GC, Sim K. Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: a decade of advance. Neurosci Biobehav Rev 2010;34(6):958–77.
   Google Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, . The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry Res 1998;59(Suppl 20):22–33;quiz 34–57.
   PubMed Web of Science ®Google Scholar
• Serretti A, Chiesa A, Porcelli S, Han C, Patkar AA, Lee SJ, . Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia. Psychiatry Res 2011;189(1):26–32.
   Google Scholar
• Pae CU, Chiesa A, Porcelli S, Han C, Patkar AA, Lee SJ, . Influence of BDNF variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia. Neuropsychobiology 2011; In press
   Google Scholar
• Young R, Biggs J, Ziegler V, Meyer D. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;133:429–35.
   PubMed Web of Science ®Google Scholar
• Hirschfeld RM, Keck PE Jr, Kramer M, Karcher K, Canuso C, Eerdekens M, . Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial. Am J Psychiatry 2004;161(6):1057–65.
   Google Scholar
• Perlis RH, Baker RW, Zarate CA Jr, Brown EB, Schuh LM, Jamal HH, . Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial. J Clin Psychiatry 2006; 67(11):1747–53.
   Google Scholar
• StatSoft I. STATISTICA for Windows. StatSoft Italia srl, Tulsa, OK; 1995.
   Google Scholar
• Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21(2):263–5.
   PubMed Web of Science ®Google Scholar
• Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
   Google Scholar
• Grigoroiu-Serbanescu M, Martinez M, Nothen MM, Grinberg M, Sima D, Propping P, . Different familial transmission patterns in bipolar I disorder with onset before and after age 25. Am J Med Genet 2001;105(8):765–73.
   Google Scholar
• Sullivan PF. Spurious genetic associations. Biol Psychiatry 2007;61(10):1121–6.
   PubMedGoogle Scholar
• Zimmerman M, Mattia JI, Posternak MA. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? Am J Psychiatry 2002;159(3):469–73.
   PubMed Web of Science ®Google Scholar